Literature DB >> 8262136

Decorin, versican, and biglycan gene expression by keloid and normal dermal fibroblasts: differential regulation by basic fibroblast growth factor.

E M Tan1, J Hoffren, S Rouda, S Greenbaum, J W Fox, J H Moore, G R Dodge.   

Abstract

Basic fibroblast growth factor (bFGF) is a multipotential heparin-binding factor that belongs to the fibroblast growth factor (FGF) family. The FGFs demonstrate a wide spectrum of biologic activities in vivo and in vitro. In this study, we investigated the potential of bFGF to regulate the expression of various dermal extracellular matrix proteoglycans and type I collagen mRNAs in cultured human fibroblasts from keloid, which is a prototype of dermal fibrosis, and normal skin tissue. We report that bFGF upregulates the expression of the decorin gene in normal and keloid fibroblasts. In contrast, the expression of biglycan is downregulated by bFGF. The mRNA steady-state level of versican, a large proteoglycan, is not altered by bFGF. Type I collagen gene expression is downregulated substantially in keloid and normal fibroblasts by bFGF. The results suggest that the expression of the proteoglycan genes are uncoordinately regulated and that the gene expression of type I collagen and biglycan is coordinately downregulated. The results also demonstrate that keloid fibroblasts respond similarly as do normal fibroblasts to bFGF in the regulation of proteoglycan and collagen expression.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262136     DOI: 10.1006/excr.1993.1302

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

1.  Modulation of sulfated glycosaminoglycan and small proteoglycan synthesis by the extracellular matrix.

Authors:  Y Wegrowski; P Gillery; G Kotlarz; C Perreau; N Georges; F X Maquart
Journal:  Mol Cell Biochem       Date:  2000-02       Impact factor: 3.396

2.  TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.

Authors:  A Berndt; H Kosmehl; U Mandel; U Gabler; X Luo; D Celeda; L Zardi; D Katenkamp
Journal:  Histochem J       Date:  1995-12

3.  The effects of ageing on wound healing: immunolocalisation of growth factors and their receptors in a murine incisional model.

Authors:  G S Ashcroft; M A Horan; M W Ferguson
Journal:  J Anat       Date:  1997-04       Impact factor: 2.610

4.  Hydrolyzed eggshell membrane immobilized on phosphorylcholine polymer supplies extracellular matrix environment for human dermal fibroblasts.

Authors:  Eri Ohto-Fujita; Tomohiro Konno; Miho Shimizu; Kazuhiko Ishihara; Toshihiro Sugitate; Jun Miyake; Kotaro Yoshimura; Kaori Taniwaki; Takashi Sakurai; Yukio Hasebe; Yoriko Atomi
Journal:  Cell Tissue Res       Date:  2011-05-20       Impact factor: 5.249

Review 5.  Regeneration of Dermis: Scarring and Cells Involved.

Authors:  Alexandra L Rippa; Ekaterina P Kalabusheva; Ekaterina A Vorotelyak
Journal:  Cells       Date:  2019-06-18       Impact factor: 6.600

Review 6.  Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies.

Authors:  Silvian Tan; Nonhlanhla Khumalo; Ardeshir Bayat
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

7.  A novel dermal matrix generated from burned skin as a promising substitute for deep-degree burns therapy.

Authors:  Guanying Yu; Lan Ye; Wei Tan; Xuguo Zhu; Yaonan Li; Duyin Jiang
Journal:  Mol Med Rep       Date:  2016-02-04       Impact factor: 2.952

Review 8.  Small Leucine-Rich Proteoglycans in Skin Wound Healing.

Authors:  Xiaoxiao Pang; Nuo Dong; Zhong Zheng
Journal:  Front Pharmacol       Date:  2020-01-28       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.